External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?-Reference-Cited by-同舟云学术

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?

Published:2021-06 Issue: Volume:28 Page:47-51
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Luiting Henk B.^ORCID,Remmers Sebastiaan,Meijer Dennie,Vis André N.,Donswijk Maarten,Oprea-Lager Daniela E.,Emmett Louise,Rauscher Isabel,Van der Poel Henk G.,Roobol Monique J.,van Leeuwen Pim J.

Publisher

Elsevier BV

Subject

Urology

Reference9 articles.

1. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy;Tendulkar;J Clin Oncol,2016

2. Assessing the optimal timing for early salvage radiation therapy in patients with prostate-specific antigen rise after radical prostatectomy;Fossati;Eur Urol,2016

3. Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen–ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy;Rauscher;Eur Urol,2018

4. Optimal timing for prostate specific membrane antigen positron emission tomography/computerized tomography in patients with biochemical recurrence after radical prostatectomy;Luiting;J Urol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography;European Urology Open Science;2024-03

2. Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters;Tomography;2023-08-15